PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds wide variation in carotid artery stenting outcomes

Odds of suffering stroke or death differ by about 50 percent from one facility to another

2015-05-18
(Press-News.org) WASHINGTON (May 18, 2015) -- Hospitals performing carotid artery stenting vary considerably in rates of in-hospital stroke or death--from 0 to 18 percent overall and from 1.2 to 4.7 percent when accounting for variation in health of patients at admission, according to a study published today in JACC: Cardiovascular Interventions.

Using data from the American College of Cardiology's CARE Registry, the largest national registry of carotid artery stent patients, researchers assessed 19,381 procedures from 188 hospitals that each performed more than five carotid artery stenting procedures between 2005 and 2013. The study was led by Beau M. Hawkins, M.D., a cardiologist at the University of Oklahoma Health Sciences Center, and Robert W. Yeh, M.D., a cardiologist at the Massachusetts General Hospital.

Carotid artery stenting is a procedure that involves inserting a mesh stent to hold open an artery after a blockage is cleared.

For patients with similar risk profiles, the odds of suffering stroke or death differ by about 50 percent from one facility to another, pointing to a substantial range in quality among hospitals performing this procedure, according to the study authors.

Results showed that the average rate of stroke or death across all patients in the study was 2.4 percent, with death or stroke rates among participating hospitals ranging from 0 to 18.8 percent. Variation is common with many cardiovascular procedures because some hospitals treat sicker patients, which could explain poorer outcomes in those facilities.

To account for differences in the patient mix, researchers did a second analysis that adjusted for variation in risk factors, including age, prior stroke, impending major surgery, and the presence of a heart flutter. Adjusted death and stroke rates ranged from 1.2 percent to 4.7 percent.

Unlike other studies, this analysis did not find a connection between procedural volume and outcomes. The authors suggest that this difference may be the result of therapeutic advances such as blood-clot protection devices and improved patient selection. They also speculate that hospitals participating in this study may have more comprehensive measures in place to promote patient safety, or they may have more rigorous credentialing standards for providers performing carotid artery stenting.

Hawkins and Yeh note that "our findings are important because they demonstrate that carotid stenting is being performed with good results across a large number of hospitals in the United States. However, our analyses also suggest that some hospitals are achieving better outcomes than others, and it will be important to identify the reasons for this so that all centers offering this therapy can achieve exceptional outcomes."

INFORMATION:

The American College of Cardiology is a 49,000-member medical society that is the professional home for the entire cardiovascular team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research, and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit http://www.acc.org.



ELSE PRESS RELEASES FROM THIS DATE:

Study: Blood thinner safe for cancer patients with brain metastases

2015-05-18
(WASHINGTON, May, 18, 2015) - Cancer patients with brain metastases who develop blood clots may safely receive blood thinners without increased risk of dangerous bleeding, according to a study, published online today in Blood, the Journal of the American Society of Hematology Cancer increases a patient's risk of developing blood clots. When a patient with cancer develops a clot, treatment with a blood thinning medication called an anticoagulant is often added to their treatment regimen in order to prevent the potentially fatal complication of blood clots traveling to ...

Adolescents, drugs and dancing

2015-05-18
In recent years, the popularity of "electronic dance music" (EDM) and dance festivals has increased substantially throughout the US and worldwide. Even though data from national samples suggests drug use among adolescents in the general US population has been declining, targeted samples have shown nightclub attendees tend to report high rates of drug use, above that of the general population. In spite of increasing deaths among dance festival attendees in recent years, no nationally representative studies have examined potential associations between nightlife attendance ...

Atrial fibrillation after surgery increases risk of heart attacks and strokes

2015-05-18
MAYWOOD, IL - As many as 12 percent of patients undergoing major, non-cardiac surgery experience an irregular heartbeat called atrial fibrillation. Post-operative atrial fibrillation (POAF) often is dismissed as a transient phenomenon. But a Loyola University Medical Center study has found that POAF can significantly increase the risk of heart attack or stroke during the first 12 months after surgery. Among bladder cancer patients who underwent a cystectomy (bladder removal) and developed POAF, 24.8 percent experienced a heart attack or stroke during the first 12 months ...

Sleep apnea linked to depression in men

2015-05-18
ATS 2015, DENVER ? Severe obstructive sleep apnea (OSA) and excessive daytime sleepiness are associated with an increased risk of depression in men, according to a new community-based study of Australian men, which was presented at the 2015 American Thoracic Society International Conference. "An association between sleep apnea and depression has been noted in some earlier studies," said lead author Carol Lang, PhD, from the University of Adelaide, Australia. "Our study, in a large community-based sample of men, confirms a strong relationship even after adjustment for ...

Noted urologist calls attention to implications of flawed prostate specific antigen data in SEER

2015-05-18
New York, NY, May 18, 2015 -- The National Cancer Institute (NCI) recently announced that it had removed all prostate specific antigen (PSA) data from the SEER (Surveillance, Epidemiology and End Results) and SEER-Medicare programs. The PSA data were removed after quality control checks revealed that a substantial number of PSA values included in the programs were incorrect. An editorial published in The Journal of Urology® explores the ramifications of the removal of these data for researchers, clinicians, and administrators within the health care community, as well ...

Stereotactic body radiation therapy appears to help some patients with pancreatic cancer

2015-05-18
Two studies from Johns Hopkins Kimmel Cancer Center researchers add to preliminary evidence that high-dose radiation treatment, called stereotactic body radiotherapy, appears to be safe and as effective as standard radiation treatment for certain patients with pancreatic cancer whose tumors are advanced but have not spread. The studies also suggest, the researchers say, that stereotactic body radiotherapy (SBRT) may have some advantages over traditional radiation for some patients, because doses can be delivered over the course of one week, unlike six or seven weeks with ...

Bigger capsules may be long-sought key for transplanting islet cells

2015-05-18
Changing the size of cell-carrying spheres may surmount the difficulties that have bedeviled diabetes researchers trying to ferry insulin-producing islet cells into hosts as a way to treat type 1 diabetes. New findings published in the journal Nature Materials suggest that for the spherical capsules, bigger may be better. Tiny gel capsules carrying islet cells allow insulin to seep out, and nutrients to get in, through microscopic holes. The holes are small enough, however, to isolate and protect the encapsulated cells from the cells of host's immune system, which would ...

Pactamycin analogs offer new, gentler approach to cancer treatment

2015-05-18
CORVALLIS, Ore. -- Researchers at Oregon State University are pursuing a new concept in treatment of epithelial cancer, especially head and neck cancer, by using two promising "analogs" of an old compound that was once studied as a potent anti-tumor agent, but long ago abandoned because it was too toxic. The analogs are more highly selective than the parent compound, pactamycin, which originally was found to kill all cells, from bacteria to mammals, by inhibiting their protein synthesis. The pactamycin analogs, which were developed with biosynthetic engineering, also ...

Gender-science stereotypes persist across the world

2015-05-18
Largest study of its type shows people associate science with men in all 66 nations studied Dominance of men in science stereotypes strongest in Scandinavian countries, especially the Netherlands Gender-science stereotypes weaker in nations with more female scientists Interactive table providing comprehensive rankings for all 66 nations EVANSTON, Ill. --- The Netherlands had the strongest stereotypes associating science with men more than women, according to a new Northwestern University study that included data from nearly 350,000 people in 66 nations. These ...

Jumping spiders are masters of miniature color vision

Jumping spiders are masters of miniature color vision
2015-05-18
Jumping spiders were already known to see in remarkably high resolution, especially considering that their bodies are less than a centimeter long. Now, researchers reporting in the Cell Press journal Current Biology on May 18 have figured out how spiders in the colorful genus Habronattus see in three color "channels," as most humans do. "The eyes of jumping spiders could not be more different from those of butterflies or birds, and yet all three tune the color sensitivities using pigments that filter light," says Nathan Morehouse of the University of Pittsburgh. "It's ...

LAST 30 PRESS RELEASES:

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

Acupuncture may help improve perceived breast cancer-related cognitive difficulties over usual care

Nerve block may reduce opioid use in infants undergoing cleft palate surgery

CRISPR primes goldenberry for fruit bowl fame

Mass General Brigham announces new AI company to accelerate clinical trial screening and patient recruitment

Fat tissue around the heart may contribute to greater heart injury after a heart attack

Jeonbuk National University researcher proposes a proposing a two-stage decision-making framework of lithium governance in Latin America

Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression

Cartilaginous cells regulate growth and blood vessel formation in bones

[Press-News.org] Study finds wide variation in carotid artery stenting outcomes
Odds of suffering stroke or death differ by about 50 percent from one facility to another